CD49d in B-cell chronic lymphocytic leukemia: Correlated expression with CD38 and prognostic relevance [4]

Leukemia

Volumn 20, Issue 3, 2006, Pages 523-525

  Zucchetto, A ^a   Bomben, R ^a   Dal Bo, M ^a   Bulian, P ^a   Benedetti, D ^a   Nanni, P ^a   Del Poeta, G ^b   Degan, M ^a   Gattei, V ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; CD19 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; B CELL LEUKEMIA; CANCER STAGING; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LETTER; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 33644503210     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404087     Document Type: Letter

References (8)

1. Pittner BT, Shanafelt TD, Kay NE, Jelinek DF. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Leukemia 2005; 19: 2264-2272.
2. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-1847.
3. Rose DM, Han J, Ginsberg MH. Alpha4 integrins and the immune response. Immunol Rev 2002; 186: 118-124.
4. Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S et al. Signature of B-CLL with different prognosis by shrunken centroids of surface antigen expression profiling. J Cell Physiol 2005; 204: 113-123.
5. Bomben R, Dal Bo M, Zucchetto A, Zaina E, Nanni P, Sonego P et al. Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: Percent mutations or antigen-driven selection? Leukemia 2005; 19: 1490-1492.
6. Degan M, Bomben R, Dal Bo M, Zucchetto A, Nanni P, Rupolo M et al. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Haematol 2004; 126: 29-42.
7. Eksioglu-Demiralp E, Alpdogan O, Aktan M, Firatli T, Ozturk A, Budak T et al. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages. Leukemia 1996; 10: 1331-1339.
8. de la Fuente MT, Casanova B, Cantero E, Hernandez DC, Garcia-Marco J, Silva A et al. Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine. Biochem Biophys Res Commun 2003; 311: 708-712.